ArticleCancers2022

Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials.

Aleksandra Wieczorek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.